Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Virginia awards $3mn to Civica to accelerate affordable insulin manufacturing at Petersburg plant Virginia awards $3M to Civica to accelerate affordable insulin production at its Petersburg plant, supporting U.S. diabetes care access and local biotech growth. bySoujanya RaviAugust 7, 2025